Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+13.96%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$250M
Cap. Flow %
-5.27%
Top 10 Hldgs %
49.5%
Holding
1,224
New
10
Increased
9
Reduced
12
Closed
13

Sector Composition

1 Real Estate 58.35%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AKCA
1051
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
$8K ﹤0.01%
530
ALK icon
1052
Alaska Air
ALK
$7.28B
$7K ﹤0.01%
248
BHR
1053
Braemar Hotels & Resorts
BHR
$203M
$7K ﹤0.01%
4,273
INVA icon
1054
Innoviva
INVA
$1.29B
$7K ﹤0.01%
572
KPTI icon
1055
Karyopharm Therapeutics
KPTI
$57.2M
$7K ﹤0.01%
24
LGND icon
1056
Ligand Pharmaceuticals
LGND
$3.25B
$7K ﹤0.01%
147
RGNX icon
1057
Regenxbio
RGNX
$490M
$7K ﹤0.01%
208
VCYT icon
1058
Veracyte
VCYT
$2.55B
$7K ﹤0.01%
276
DRNA
1059
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7K ﹤0.01%
386
LMNX
1060
DELISTED
Luminex Corp
LMNX
$7K ﹤0.01%
254
ITCI
1061
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
364
AKBA icon
1062
Akebia Therapeutics
AKBA
$785M
$6K ﹤0.01%
740
BBWI icon
1063
Bath & Body Works
BBWI
$6.06B
$6K ﹤0.01%
599
CHRS icon
1064
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$6K ﹤0.01%
396
EDIT icon
1065
Editas Medicine
EDIT
$248M
$6K ﹤0.01%
304
ENTA icon
1066
Enanta Pharmaceuticals
ENTA
$189M
$6K ﹤0.01%
111
HRB icon
1067
H&R Block
HRB
$6.85B
$6K ﹤0.01%
419
MYGN icon
1068
Myriad Genetics
MYGN
$615M
$6K ﹤0.01%
420
TWST icon
1069
Twist Bioscience
TWST
$1.55B
$6K ﹤0.01%
211
WNS icon
1070
WNS Holdings
WNS
$3.24B
$6K ﹤0.01%
150
YMAB icon
1071
Y-mAbs Therapeutics
YMAB
$390M
$6K ﹤0.01%
224
TCDA
1072
DELISTED
Tricida, Inc. Common Stock
TCDA
$6K ﹤0.01%
280
ZGNX
1073
DELISTED
Zogenix, Inc.
ZGNX
$6K ﹤0.01%
250
ESPR icon
1074
Esperion Therapeutics
ESPR
$540M
$5K ﹤0.01%
154
SUPN icon
1075
Supernus Pharmaceuticals
SUPN
$2.58B
$5K ﹤0.01%
296